The PE Ratio as of November 2024 (TTM) for CONMED Corporation (CNMD) is 17.75

According to CONMED Corporation’s latest financial reports and current stock price. The company's current PE Ratio is 17.75. This represents a change of -16.31% compared to the average of 21.21 of the last 4 quarters.

CONMED Corporation (CNMD) Historical PE Ratio (quarterly & annually)

How has CNMD PE Ratio performed in the past?

The mean historical PE Ratio of CONMED Corporation over the last ten years is 76.40. The current 17.75 PE Ratio has changed 2.22% with respect to the historical average. Over the past ten years (40 quarters), CNMD's PE Ratio was at its highest in in the March 2019 quarter at 570.36. The PE Ratio was at its lowest in in the March 2016 quarter at -128.32.

CONMED Corporation (CNMD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of CONMED Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CONMED Corporation (CNMD) Average PE Ratio

How has CNMD PE Ratio performed in the past?

The current PE Ratio of CONMED Corporation (CNMD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

CONMED Corporation (CNMD) PE Ratio vs. Peers

How is CNMD’s PE Ratio compared to its peers?

CONMED Corporation’s PE Ratio is less than NuVasive, Inc. (56.43), greater than OrthoPediatrics Corp. (-21.46), greater than Pulmonx Corporation (-4.67), greater than SI-BONE, Inc. (-14.01), less than Globus Medical, Inc. (125.55), greater than Orthofix Medical Inc. (-6.11), greater than Alphatec Holdings, Inc. (-8.12), less than LivaNova PLC (117.78), less than Integer Holdings Corporation (40.94), greater than iRhythm Technologies, Inc. (-15.35), greater than Heska Corporation (-67.36), greater than Surmodics, Inc. (-48.35), greater than Sight Sciences, Inc. (-4.01), greater than Glaukos Corporation (-52.99), less than STERIS plc (48.74), greater than Anika Therapeutics, Inc. (-2.57),

Build a custom stock screener for CONMED Corporation (CNMD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CONMED Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CONMED Corporation (CNMD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CONMED Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.